CA1038763A - Pharmaceutical compositions comprising biphenyl derivatives - Google Patents

Pharmaceutical compositions comprising biphenyl derivatives

Info

Publication number
CA1038763A
CA1038763A CA218,135A CA218135A CA1038763A CA 1038763 A CA1038763 A CA 1038763A CA 218135 A CA218135 A CA 218135A CA 1038763 A CA1038763 A CA 1038763A
Authority
CA
Canada
Prior art keywords
pharmaceutical preparation
preparation according
compounds
phenyl
chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA218,135A
Other languages
English (en)
French (fr)
Other versions
CA218135S (en
Inventor
Alain Rancurel
Jean-Maurice Gazave
Georges Grenier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Pharmascience SA
Original Assignee
Laboratoires Pharmascience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Pharmascience SA filed Critical Laboratoires Pharmascience SA
Application granted granted Critical
Publication of CA1038763A publication Critical patent/CA1038763A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA218,135A 1974-01-15 1975-01-14 Pharmaceutical compositions comprising biphenyl derivatives Expired CA1038763A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7401228A FR2257272B1 (enExample) 1974-01-15 1974-01-15

Publications (1)

Publication Number Publication Date
CA1038763A true CA1038763A (en) 1978-09-19

Family

ID=9133467

Family Applications (1)

Application Number Title Priority Date Filing Date
CA218,135A Expired CA1038763A (en) 1974-01-15 1975-01-14 Pharmaceutical compositions comprising biphenyl derivatives

Country Status (7)

Country Link
US (1) US4015017A (enExample)
BE (1) BE824359A (enExample)
CA (1) CA1038763A (enExample)
DE (1) DE2501443C2 (enExample)
FR (1) FR2257272B1 (enExample)
GB (1) GB1495331A (enExample)
NL (1) NL179872C (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377202A2 (fr) * 1977-01-12 1978-08-11 Pharmascience Lab Compositions pharmaceutiques contenant de l'hexahydroxy-2,3,4,3',4',5'-benzophenone
ES2043766T3 (es) * 1987-11-11 1994-01-01 Pharmascience Lab Una nueva composicion farmaceutica que comprende exifona y un polimero soluble en agua.
GB9212673D0 (en) * 1992-06-15 1992-07-29 Celltech Ltd Chemical compounds
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
GB9226830D0 (en) * 1992-12-23 1993-02-17 Celltech Ltd Chemical compounds
US5622977A (en) * 1992-12-23 1997-04-22 Celltech Therapeutics Limited Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
DE69418947T2 (de) * 1993-03-10 1999-12-23 Morinaga Milk Industry Co. Ltd., Tokio/Tokyo Stilbenderivate und analoga sowie deren anwendung
EP0738268B1 (en) * 1993-12-22 2004-03-03 Celltech R&D Limited Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
US6245774B1 (en) 1994-06-21 2001-06-12 Celltech Therapeutics Limited Tri-substituted phenyl or pyridine derivatives
GB9412571D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412573D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412672D0 (en) * 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
US5977077A (en) * 1995-08-28 1999-11-02 Interlab Corporation Xanthone analogs for the treatment of infectious diseases
GB9523675D0 (en) * 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9526246D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9526245D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9526243D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
GB9622363D0 (en) 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
GB9625184D0 (en) * 1996-12-04 1997-01-22 Celltech Therapeutics Ltd Chemical compounds
AU5330698A (en) 1996-12-23 1998-07-17 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9705361D0 (en) 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
GB9914258D0 (en) * 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB9924862D0 (en) 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds
AU4515701A (en) 1999-12-02 2001-06-18 Interlab, Inc. Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins
IL159120A0 (en) * 2001-05-29 2004-05-12 Schering Ag Cdk inhibiting pyrimidines, production thereof and their use as medicaments
MXPA05009434A (es) * 2003-03-05 2005-11-23 Celgene Corp Compuestos de difeniletileno y usos de los mismos.
CN103449998A (zh) * 2013-08-26 2013-12-18 曹庸 非均相合成2,3,4,4′-四羟基二苯甲酮的方法
MX2018007458A (es) * 2015-12-17 2018-11-29 Massachusetts Inst Technology Composiciones de benzofenonas polihidroxiladas y metodos para el tratamiento de trastornos neurodegenerativos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3068151A (en) * 1958-05-19 1962-12-11 Procter & Gamble Hair control composition
BE690791A (enExample) * 1966-12-07 1967-05-16
US3850988A (en) * 1971-09-07 1974-11-26 Gaf Corp Purification of benzophenones
US3862982A (en) * 1972-06-16 1975-01-28 Robins Co Inc A H 2-(Omega-substituted alkoxy) benzophenones

Also Published As

Publication number Publication date
DE2501443C2 (de) 1984-06-14
BE824359A (fr) 1975-05-02
GB1495331A (en) 1977-12-14
NL179872C (nl) 1986-12-01
NL179872B (nl) 1986-07-01
NL7500451A (nl) 1975-07-17
US4015017A (en) 1977-03-29
DE2501443A1 (de) 1975-07-24
FR2257272B1 (enExample) 1978-08-25
FR2257272A1 (enExample) 1975-08-08

Similar Documents

Publication Publication Date Title
US4015017A (en) Certain biphenyl derivatives used to treat disorders caused by increased capillary permeability
CA1084064A (en) Method for preparing 2'-(carboxymethoxy)-chalcones
US3928421A (en) Anti-gastric ulcer chalcone ethers
Cairns et al. Synthesis and structure-activity relations of disodium cromoglycate and some related compounds
AU2005249493A1 (en) Diarylalkanes as potent inhibitors of binuclear enzymes
EP0464858A1 (en) A lipoxygenase inhibitor
JP2554322B2 (ja) ５−リポキシゲナ−ゼ阻害剤としての２−置換−１−ナフト−ル類
EP0289506A1 (en) Lipoxygenase inhibitors
US6518315B1 (en) Medicinal uses of phenylaikanols and derivatives
Paris et al. Glycerides as prodrugs. 1. Synthesis and antiinflammatory activity of 1, 3-bis (alkanoyl)-2-(O-acetylsalicyloyl) glycerides (aspirin triglycerides)
AU4085799A (en) Novel diphenylethylene compounds
JPS5921850B2 (ja) 新ナフタレン誘導体の製法
CA2307028C (en) Medicinal uses of phenylalkanols and derivatives
US4116972A (en) Anti-inflammatory 1-oxo-isoindoline derivatives and processes for their preparation
EP1507523A1 (en) Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
ES2322906T3 (es) Nuevos derivados fenolicos y agente preventivo/terapeutico antitripanosoma que contiene estos mismos derivados como ingrediente activo.
US4272529A (en) O-Alcoxycarbonylphenyl esters of anthranilic acid with therapeutical activity, method for their preparation and related pharmaceutical composition
JPS6033373B2 (ja) １−ナフチル酢酸誘導体、その製造法ならびに１−ナフチル酢酸誘導体を含有する薬剤
JP3144662B2 (ja) スチルベン誘導体とスチルベン同族体誘導体及びそれらの用途
JPS6045172B2 (ja) カルコン誘導体
EP1572614A2 (en) New method for the preparation of 1,5-bis(4-hydroxy-3-metoxy-phenyl)-penta-1,4-dien-3-one and derivatives with antitumoral properties
JPS6144836A (ja) 置換スチレン誘導体
Wyrick et al. Effects of molecular modification on hypocholesteremic activity of 1, 3-bis (substituted phenoxy)-2-propanones and related derivatives
US3896234A (en) Pharmaceutical composition and method employing phenylvulpinic acid derivatives
AU758911B2 (en) Medicinal uses of phenylalkanols and derivatives